Ocular Therapeutix price target raised to $15 from $14 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on Ocular Therapeutix (OCUL) to $15 from $14 and keeps a Buy rating on the shares ...
Promising Advancements in Poseida Therapeutics’ Cell Therapy Drive Buy Rating
H.C. Wainwright analyst Arthur He CFA has maintained their bullish stance on PSTX stock, giving a Buy rating today. Arthur He CFA has given ...
bovnews22m
Joby Aviation Inc (JOBY) Stock Sees Market Value Hit $4.52 billion: What Are the Implications?
On Thursday, Joby Aviation Inc (JOBY) stock saw a modest uptick, ending the day at $5.91 which represents a slight increase of $0.01 or 0.17% from the prior close of $5.9. The stock opened at $5.95 ...